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Abstract
DNA Replication initiates by formation of a pre-replication complex on sequences termed origins. In eukaryotes, the pre-
replication complex is composed of the Origin Recognition Complex (ORC), Cdc6 and the MCM replicative helicase in
conjunction with Cdt1. Eukaryotic ORC is considered to be composed of six subunits, named Orc1–6, and monomeric Cdc6
is closely related in sequence to Orc1. However, ORC has been little explored in protists, and only a single ORC protein,
related to both Orc1 and Cdc6, has been shown to act in DNA replication in Trypanosoma brucei. Here we identify three
highly diverged putative T. brucei ORC components that interact with ORC1/CDC6 and contribute to cell division. Two of
these factors are so diverged that we cannot determine if they are eukaryotic ORC subunit orthologues, or are parasite-
specific replication factors. The other we show to be a highly diverged Orc4 orthologue, demonstrating that this is one of
the most widely conserved ORC subunits in protists and revealing it to be a key element of eukaryotic ORC architecture.
Additionally, we have examined interactions amongst the T. brucei MCM subunits and show that this has the conventional
eukaryotic heterohexameric structure, suggesting that divergence in the T. brucei replication machinery is limited to the
earliest steps in origin licensing.
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Introduction
Genome replication is central to the propagation of all life. In
DNA genomes, replication initiates by the designation of genome
sequences as origins, where synthesis of a copy of the genetic
material begins. Origin designation is a complex, tightly regulated
process whose core mechanisms and machinery are conserved
between eukaryotes and archaea [1,2]. This reaction involves the
formation of a pre-replication complex (pre-RC), which in
eukaryotes comprises the Origin Recognition Complex (ORC),
Cdc6, Cdt1 and the replicative MCM helicase; for reviews, see [3–
6]. ORC is frequently described as being composed of six subunits,
named Orc1–6, in all eukaryotes that have been examined to date
[7]. It is the earliest acting pre-RC component during DNA
replication origin designation, being responsible for binding to
origins. ORC was first purified from Saccharomyces cerevisiae [8], and
the subunits were numbered in descending order of size.
Orthologues of each subunit have subsequently been identified
from a range of eukaryotes [7]. Orcs1–5 each display sequence
conservation with the AAA
+ family of ATPases, including Walker
A and B box nucleotide binding domains and sensor motifs
involved in nucleotide hydrolysis [9]. Winged helix domains are
normally found at the C-termini of these subunits, which may
mediate DNA binding in association with the AAA+ ATPase
domain [10–12]. Orc1 in most eukaryotes also possesses N-
terminal homology with Sir3, which is involved in transcriptional
silencing, including a bromo-adjacent homology (BAH) domain
[13]. Orc6 is more poorly conserved amongst eukaryotes [14] and
appears unrelated to the other ORC subunits, lacking discernible
homology with AAA+ domains [7]. ATP binding and hydrolysis
by the ORC subunits causes conformational changes associated
with ORC assembly and DNA binding, as well as modulating
interaction with the other pre-RC components [12,15–18].
Cdc6 (Cell Division Cycle 6) was first identified in S. cerevisiae
[19], where the gene is transcribed only in late G1 and early S-
phase [20]. It is an AAA+ ATPase closely related to Orc1, also
possessing a C-terminal winged helix domain, and phylogenetics
suggest the proteins arose from a common ancestor [7,21]. In
yeast, Cdc6 is recruited to ORC bound to origin DNA, and the
protein’s ATPase activity modulates the structure of the ternary
complex [12,16,22–24]. A consequence of this binding is the
recruitment of Cdt1 (Cdc10-dependent transcript 1), a protein
originally identified in Schizosaccharomyces pombe whose expression is
cell cycle-regulated [25]. Cdt1 has been identified in a number of
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homology and lack clear enzymatic motifs [26]. Cdt1 acts as an
adaptor protein that mediates interaction between the MCM
helicase and the ORC-Cdc6 complex [27,28] and, at least in yeast,
forms a stable complex with MCM [24]. In eukaryotes, the
replicative MCM (Mini Chromosome Maintenance) helicase is
composed of six conserved subunits, named Mcm2–7, which form
a hetero-hexameric ring on DNA. Binding of MCM completes the
pre-RC complex and ‘licenses’ origins to be replicated. Subse-
quent steps involve the binding of further factors, including DNA
polymerases [4].
The pre-RC machinery of archaea is evolutionarily conserved
with that of eukaryotes, though appears to be simpler in
architecture [1,2]. A single protein, Orc1/Cdc6, fulfils the
functions of eukaryotic ORC and Cdc6. In some archaeal species
only a single Orc1/Ccd6 gene is found, while in others greater
numbers are present [29]. Characterised archaeal Orc1/Cdc6
proteins bind in a sequence-specific manner to replication origins,
possess ATPase activity that may be due to co-operative
interactions between monomers, and distort the origin DNA on
binding, suggesting they designate origins in similar ways to
eukaryotic ORC [10,11]. The archaeal MCM helicase is a
homohexamer, and thus structurally distinct from the eukaryotic
heterohexamer [30]. An orthologue of Cdt1 has not been
described in archaea, though a protein named Winged helix
initiator Protein (WhiP) has been identified that possesses sequence
similarity with Cdt1 and has been shown to bind origins [31].
Whether this acts analogously to eukaryotic Cdt1 is currently
unclear, and direct interaction between Orc1/Cdc6 and MCM
has been described in a number of archaeal species, perhaps
suggesting that recruitment in these organisms may not need a
Cdt1-like adaptor [32–34].
In protists, unicellular microbes that represent much of the
diversity of the eukaryotic kingdom and include a number of
important pathogens [35,36], the pre-RC machinery has been
examined only to a limited extent. In the apicomplexan parasite
Plasmodium falciparum, functional analysis has examined two
components of a putative ORC complex, Orc1 and Orc5
[37,38]. P. falciparum Orc1 appears to be significantly enlarged
relative to most eukaryotic Orc1 orthologues, possessing N- and C-
terminal extensions, and co-localises with MCM during replicative
life cycle stages [39]. In Tetrahymena thermophila a multisubunit
ORC complex has also been described [40,41]. In contrast,
bioinformatic analyses of the genomes of T. brucei and related
kinetoplastid parasites identified only a single ORC-related protein
[21,42,43]. This protein contains well-conserved AAA+ ATPase
motifs and is related in sequence to both Orc1 and Cdc6, though
lacks N-terminal sequences found in other eukaryotic Orc1
subunits, including the BAH domain. The structural similarity of
the kinetoplastid proteins to Orc1/Cdc6 in archaea has led to their
re-naming as ORC1/CDC6 [43,44]. TbORC1/CDC6 is able to
complement S. cerevisiae cdc6 temperature sensitive mutants (but not
orc1 mutants), arguing the protein has Cdc6-related properties
[43]. Given this finding, and the apparent absence of further ORC
subunits, the possibility that origin designation in these parasites
may be archaeal-like has been discussed [21]. However, a factor,
named ORC1b, was identified very recently that contains
conserved ATPase motifs and interacts with ORC1/CDC6,
perhaps suggesting a larger ORC [45]. Here, we describe the
identification of three further T. brucei proteins that interact with
TbORC1/CDC6. One of these factors we show to be a diverged
orthologue of Orc4, suggesting that this is a core, conserved
component of eukaryotic ORC. This finding suggests that an
ORC is present in T. brucei, though it is highly diverged. In support
of this, we show that RNAi knockdown TbORC1/CDC6 or any
of the three interacting factors results in striking phenocopying in
both tsetse fly- and mammal-infective T. brucei, suggesting
functional overlap. Finally, we describe a sub-complex of the T.
brucei MCM helicase, which suggests a conserved topology with
other eukaryotic MCM helicases.
Results
The T. brucei MCM helicase is a conserved heterohexamer
In eukaryotes Cdc6 and Cdt1 function to recruit the MCM
helicase complex for local DNA unwinding by mediating
interaction with ORC [6]. Homology searches have failed to
identify a Cdt1 homologue in any trypanosomatid genome
[21,42]. A mechanistic consequence of such a putative absence
could be that MCM in T. brucei is recruited directly by TbORC1/
CDC6. If correct, this would lend support to the suggestion that
the very earliest steps in origin designation in T. brucei may be
archaeal-like, and may relate to the potential that TbORC1/
CDC6 provides both Cdc6 and Orc1 functions. Such direct
interaction between one or more subunits of ORC and MCM has
not been reported in eukaryotes [28], but has been seen between
archaeal ORC1/CDC6 and the replicative helicase in a number
of species by different methods [32–34]. We therefore decided to
test this experimentally in T. brucei.
Unlike in archaea, where the replicative helicase is a homo-
hexamer [2], orthologues of all six core eukaryotic MCM subunits,
named Mcm2–7 [4], can be unambiguously identified in the T.
brucei genome (Fig. 1A,B). In addition, putative MCM8 and
MCM9 orthologues appear to be present [46]. To test if
TbORC1/CDC6 directly interacts with the MCM2–7 helicase,
we generated constructs that allow us to C-terminally tag
TbORC1/CDC6 with 12 copies of the Myc epitope, and to C-
terminally tag each of the MCM subunits with six copies of the
HA epitope. We first generated procyclic form (PCF) cells
expressing TbORC1/CDC6-Myc, and these were then trans-
formed individually with the six MCM subunit tagging constructs.
Clones were obtained that expressed proteins reacting with anti-
HA antiserum that were of the size expected for HA-tagged
variants of each of the TbMCM subunits (Fig. 1C). In each case,
co-expression of TbORC1/CDC6-Myc was confirmed by hy-
bridisation with anti-Myc antibody (Fig. 1C). From the western
blots it is evident that the individual HA-tagged TbMCM subunits
were detected at different levels by the anti-HA antisera (with
TbORC1/CDC6-Myc serving as a loading control). Visual
inspection indicated TbMCM2 generated the weakest signal,
followed by TbMCM7, and TbMCM3, -4 and -6 gave the same,
higher levels. Clones expressing HA-MCM5 were recovered later
and the level of expression of this protein appeared low relative to
the other MCM subunits (data not shown); these clones were not
analysed further.
To identify TbMCM subunit interaction partners, we per-
formed immunoprecipitation (IP) of HA-tagged TbMCM3,
TbMCM6 and TbMCM7 with anti-HA antiserum and separated
the IP eluates on an SDS-PAGE gel. Colloidal Coomassie staining
revealed distinct patterns of bands for TbMCM7-HA (4 bands),
TbMCM6-HA (3 bands) and TbMCM3-HA (1 band) that were
absent in an anti-HA IP control from the TbORC1/CDC6-Myc
cells (Fig. 2). Each band was excised and protein fingerprinted by
Liquid Chromatography-Electrospray Tandem Mass Spectrome-
try (LC-ES MS/MS). The resulting MS/MS spectra were used to
interrogate the T. brucei genome database (TritrypDB) using
MASCOT software and each band yielded at least 11 unique
peptides (MASCOT score of greater than 30; p,0.05) that
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data show the following: IP of TbMCM6-HA coIPs TbMCM2 and
TbMCM4; IP of TbMCM7-HA co-IPs TbMCM2, TbMCM4 and
TbMCM6; and the single band excised from the TbMCM3-HA IP
was TbMCM3 itself. Thus, we find that a subcomplex can be
detected containing TbMCM2, TbMCM4, TbMCM6 and
TbMCM7 in PCF whole cell extracts in the absence of cross-
linking. Such an MCM sub-complex has been described in several
eukaryote species [4], suggesting that this aspect of TbMCM
helicase structure is conserved. We did not, however, detect
interaction between the above subcomplex and TbMCM3 or
TbMCM5, nor did IP of TbMCM3-HA reveal interaction with
TbMCM5. This approach also did not reveal co-IP of TbORC1/
CDC6 and any of the TbMCM subunits analysed.
To probe further the interactions between T. brucei MCM
subunits, we used yeast 2-hybrid analysis, co-expressing pairwise
combinations of the six proteins as both ‘bait’ and ‘prey’ (Fig. 2C;
more detailed analysis in Fig. S1). In contrast to the extensive
intersubunit interactions observed for human Mcm proteins [47] in
such analysis, including between each putative adjacent MCM
subunit in the hexamer, we detect more limited interactions
(summarised in Fig. 2D). Nevertheless, this analysis suggests that
TbMCM3 and TbMCM5, which are thought to form a
subcomplex that was not detected by IP, can interact, and that
both of these subunits can interact with two further subunits of the
putative TbMCM2/6/4/7 subcomplex. Taken together, these data
are compatible with the order of MCM subunits that has been
proposed for the eukaryotic replicative helicase heterohexamer [4].
Testing for interaction between TbORC1/CDC6 and
TbMCM
To test more directly for TbORC1/CDC6 and TbMCM
interactions we next used anti-HA antiserum to precipitate
TbMCM3-HA, TbMCM6-HA or TbMCM7-HA from whole
cell extracts of the double-tagged cells co-expressing TbORC1/
CDC6-Myc. Probing the inputs and eluates with anti-HA
antibody showed that each TbMCM subunit could be recovered
by IP from the double tagged cells, but not from a control cell
Figure 1. MCM helicase subunits in T. brucei and co-expression with ORC1/CDC6 as epitope tagged variants. A. An unrooted
phylogenetic tree is shown, detailing the homology between predicted MCM helicase subunits in T. brucei (Tbr) relative to orthologues in H. sapiens
(Hsa), S. cerevisiae (Sce) and A. thaliana (Ath). Complete protein sequences were aligned with ClustalX, using default settings, and the phylogenetic
tree was displayed using TreeView (Page, 1996); the distance corresponding to 10 amino acid changes per 100 positions is indicated (0.1) B. A
diagrammatic representation of the MCM helicase subunits in T. brucei. The length of the predicted polypeptides is shown (in amino acid residues),
and the position of conserved functional motifs are indicated: an N-terminal Zinc Finger (Zn, blue box); and Walker A and B boxes (A and B, red
boxes), an Arginine finger (R, orange box) and sensor 1 and 2 motifs (S1 and S2, green boxes), all involved in nucleotide binding and hydrolysis. C.
Western blots of procyclic form TREU 927 T. brucei cells co-expressing C-terminally HA-tagged TbMCM subunits (MCM-HA) and C-terminally Myc-
tagged TbORC1/CDC6. The upper panel shows TbMCM-HA expression in whole cell extracts, detected using anti-HA antibody, and the bottom panel
shows TbORC1/CDC6-Myc from the same whole cell extracts detected using anti-Myc antibody. Single clones are shown for TbMCM4-HA and
TbMCM6-HA, two clones for TbMCM2-HA and TbMCM7-HA, and three clones for TbMCM3-HA. Size markers (kDa) are indicated.
doi:10.1371/journal.pone.0032674.g001
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tagged TbMCM subunit (Fig. 3A). Probing the same samples with
anti-myc antibody failed to reveal evidence for interaction between
any of the three TbMCM subunits analysed and TbORC1/
CDC6-Myc, which was clearly detectable in the input samples.
Since TbMCM might only interact with chromatin-bound
TbORC1/CDC6 at replication origins, it is possible that a
substantial portion of the cellular pool of TbMCM may be
unbound to DNA/TbORC1/CDC6, masking any interactions
from being detected by IP of an MCM subunit. We therefore
carried out the reciprocal IP, using anti-Myc antibody to recover
TbORC1/CDC6-Myc from cell extracts. To do this, we
generated cells expressing only TbMCM6-HA or TbMCM7-HA
(Fig. 3B), providing controls for TbMCM6-HA, TbORC1/
CDC6-Myc and TbMCM7-HA, TbORC1/CDC6-Myc double
expressers. Probing the input and eluate samples from the four
cells showed that anti-Myc IP recovered a band of the expected
size for TbORC1/CDC6-Myc from both double-tagged cells that
was, as expected, absent from the TbMCM-HA control cells.
However, immunoblotting for TbMCM6-HA or TbMCM7-HA
using anti-HA antibody did not detect the proteins in the eluates
from any of the IPs (Fig. 3B), suggesting that interaction with
TbORC1/CDC6-Myc is undetectable in these conditions.
Identification of three novel ORC1/CDC6-interacting
factors
Having shown that it is possible to efficiently IP TbORC1/
CDC6-Myc from T. brucei PCF cell extracts, we next asked if we
Figure 2. Mass spectrometric characterisation of T. brucei TbMCM-HA immunoprecipitates and yeast two hybrid analysis reveals
MCM subunit interactions. A. Eluates are shown from immunoprecipitations (IP) using anti-HA antibody from T. brucei cell lines co-expressing
TbORC1/CDC6-Myc and TbMCM3-HA, TbMCM-6HA or TbMCM7-HA; as a control an IP eluate from a cell expressing TbORC1/CDC6-Myc, but no HA-
tagged protein, is also shown. Proteins in the IP eluates were separated by SDS-PAGE and visualised by colloidal commassie staining; size markers are
shown and Ig indicates immunoglobulin polypeptides. Bands that were excised and analysed by mass spectrometry are numbered; the results of this
analysis are shown in B, where the number of unique peptides identified for each band is shown, as well as the T. brucei gene ID and MCM subunit. C.
Inter-MCM subunit interactions were examined by yeast 2 hybrid analysis. Growth of yeast clones co-expressing individual TbMCM subunits
(numbered 2–7, indicating TbMCM2–7) as fusions with the Gal DNA binding domain (pGBK-MCM) and with the Gal activating domain (pGAD-MCM) is
shown; as a control, growth of the fusion protein-expressing plasmids are shown when co-transformed with pGBK or pGAD vectors without any MCM
gene insert (V). Growth on minimal medium lacking tryptophan, leucine and histidine (-T-L-H) indicates weak interaction, while growth on the same
media supplemented with Aureobasidin A (-T-L-H+AbA) or 39 aminotriazole (-T-L-L+3-AT), indicates strong interaction; growth on medium lacking
only tryptophan and lecuine (-T-L) shows that the cells that cannot grow through interaction are viable. D shows a model for the assembly and
subunit architecture of the MCM hexamer in eukaryotes; a putative subunit complex identified by IP in this analysis is indicated (dashed box), while
intersubunit interactions revealed by yeast 2 hybrid analysis are shown in the putative heterohexamer (single- and doubled-headed arrows denote
one- and bi-directional interactions, respectively, and strong and weak interactions are distinguished by solid and dashed lines, respectively).
doi:10.1371/journal.pone.0032674.g002
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this, whole cell extracts were prepared from PCF TbORC1/
CDC6-Myc cells and from untagged (TREU927 wild type, PCF)
cells and subjected to IP. Eluates from each IP were separated by
10% SDS-PAGE, which revealed a large number of bands in
each, with no obvious differences by visual inspection (data not
shown). Proteins throughout the gel lanes, from each IP, were
excised and analysed by LC-ES MS/MS and the resulting MS/
MS spectra were used to interrogate the T. brucei genome
(TritrypDB). These data were first filtered by excluding all
individual proteins that were common to both IP eluates, and
further filtered by excluding proteins that were only present in the
TbORC1/CDC6-myc eluate but where proteins that they were
likely to functionally interact with were present in the control IP
eluate (such as ribosomal proteins or translation factors), or with
clear non-nuclear functions. We then ranked the resulting
TbORC1/CDC6-Myc IP-specific proteins according to the
number of unique peptide hits/protein observed in the MS/MS.
TbORC1/CDC6 was thus revealed (10 unique peptides),
validating the approach. To further limit our analysis, we
considered only proteins recognised by .3 peptides, all of which
have not been ascribed potential functions experimentally or by
sequence homology. For each polypeptide, position-specific
iterative (psi) BLAST, Protein Homology/analogY Recognition
Engine (PHYRE) and PFAM searches were carried out. This
revealed three proteins that could potentially be related to
eukaryotic ORC subunits, or Cdc6 (see below), and were therefore
analysed further: Tb09.160.3120 (10 peptides), Tb927.10.13380
(10 peptides) and Tb927.10.7980 (4 peptides). To test whether
these proteins interact with TbORC1/CDC6, constructs were
generated that allow each to be expressed as a C-terminal fusion
with six copies of the HA epitope, after integration into the
endogenous loci. The constructs were transformed into the
TbORC1/CDC6-Myc tagged PCF line cell line and clones
selected in which expression of the tagged proteins was validated
by westerns (data not shown). As controls, the constructs were also
transformed into WT PCF cells and clones expressing each HA-
tagged protein were similarly validated (data not shown).
IP analysis of Tb927.10.13380 (Tb13380) is shown in Fig. 4A.
Anti-HA antiserum was used first to IP Tb13380-HA from whole
cell extracts of double-tagged cells co-expressing TbORC1/
CDC6-Myc and Tb13380-HA, and from a control cell expressing
only myc-tagged TbORC1/CDC6. Probing western blots of the
inputs and elutes from the IPs with anti-HA antibody showed that
Tb13380-HA was recovered by IP from the double tagged cells,
but not from the control. Probing the same samples with anti-myc
showed that TbORC1/CDC6-Myc was also recovered, indicating
interaction. The reciprocal experiment confirmed this interaction:
anti-myc antiserum was able to IP TbORC1/CDC6-Myc from
the Tb13380HA, TbORC1/CDC6Myc double expresser cell,
and Tb13380-HA was also recovered. The same IP did not
recover Tb13380-HA from the single expresser control.
Second iteration psiBLAST searches of the NCBI database
using the Tb13380-predicted polypeptide sequence (713 amino
acid residues) identified Drosophila melanogaster (Dme)Orc4 (E-value,
9e-14), and then Orc4 subunits from further organisms at lower,
yet highly significant, expectancy values (0.003#E-value#1e-13).
In the reciprocal BLAST search, using DmeOrc4 sequence to
query TritrypDB, the ‘top’ hit (E-value, 0.0021) was Tb13380. To
examine if Tb13380 displays broader sequence homology with
eukaryotic Orc4 subunits, the complete predicted sequence of
Tb13380 was aligned with a range of Orc4 polypeptides, both
from organisms in which the protein has been functionally
characterised and from other organisms (primarily protists) where
we could recover putative ORC4 homologues by database
searches (Fig. 4B). Overall, Tb13380 displays limited amino acid
sequence homology with Orc4 subunits (for example, 33%
similarity and 16% identity with DmeOrc4, and 33% similarity
and 15% identity with Arabidopsis thaliana Orc4). However, in
phylogenetic trees Tb13380 groups robustly with Orc4, when all
other ORC subunits are considered (Fig. S2). We conclude that
Tb927.10.13380 encodes a divergent orthologue of the Orc4
subunit of eukaryotic ORC. Homology with Walker A and B
boxes, and a sensor 1 motif, found within AAA+ ATPase proteins
[9,12] can be identified. However, it is not clear that TbORC4,
and indeed a number of the other putative protistan Orc4
homologues, are functional NTPases, since they lack critical,
conserved residues. TbORC4 lacks a crucial lysine residue (K62 of
DmeOrc4; K108 of S. cerevisiae Orc4; K114A in Tb13380) in the
Walker A motif, which binds the nucleotide, and the Walker B
motif, which binds Mg++, appears degenerate. A further
important motif (arginine finger, or box VII) possesses a key
arginine residue proposed to interact with the c-phosphate of the
adenine nucleotide [9,48]. This interaction is needed to coordinate
Figure 3. Western blot analysis of TbORC1/CDC6-Myc and TbMCM-HA immunoprecipitations. A. Input (I) and eluate (E) samples from
immunoprecipitations (IPs) from procyclic form whole cell extracts using antibody against HA are shown from cells co-expressing TbORC1/CDC6-Myc
(ORC-myc) and TbMCM3-HA, TbMCM6-HA or TbMCM7-HA, as well as from control cells expressing only Myc-tagged TbORC1/CDC6. Samples were
separated on a 10% SDS-PAGE gel, transferred to a membrane and probed with anti-HA antibody (upper panel) or with anti-Myc antibody (lower
panel). B shows the reciprocal experiment in which IP was performed with anti-Myc antibody from cells co-expressing TbORC1/CDC6-Myc and
TbMCM6-HA or TbMCM7-HA, and from control cells expressing only HA-tagged MCM6 or MCM7. Size markers (kDa) are indicated.
doi:10.1371/journal.pone.0032674.g003
Origin Recognition Complex Factors in T. brucei
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e32674ATP hydrolysis with a conformational change, a critical feature of
protein-protein interactions [48]. The arginine finger, and
surrounding sequence, appears to be well conserved between
TbORC4 and other eukaryotic Orc4 proteins. TbORC4 is
conserved and syntenic across the sequenced kinetoplastids:
orthologues, annotated as hypothetical proteins, can be found in
T. cruzi (Tc00.1047053506357.20 and Tc00.1047053511277.92,
54% identity with Tb13380) and L. major (LmjF18.0720, 38%
identity with Tb13380).
Analysis of TbORC1/CDC6 interaction with Tb09.10.3120
(Tb3120) and Tb927.10.7980 (Tb7980) is shown in Fig. 5. Anti-
HA antibody was used to IP Tb7980-HA from a TbORC1/
CDC6-Myc, Tb7980-HA double expresser cell and Tb3120-HA
from a TbORC1/CDC6-myc, Tb3120-HA double expresser; IP
was also performed with anti-HA antibody from a control
TbORC1/CDC6-Myc single expresser cell. For Tb3120,
probing with anti-HA antibody showed that the protein was
efficiently recovered by IP from the double expresser cells, but
not from the control. It was not possible to evaluate fully the
success of the IP of Tb7980-HA from the double expresser,
because Tb7980-HA nearly co-migrates with the IgG heavy
chain fragment in the antibody used for the IP, and this is seen in
the western blot strategy adopted here. Nevertheless, for both
IPs, the anti-Myc blot revealed a band of the expected size for
TbORC1/CDC6-Myc in the eluate from the TbORC1/CDC6-
Myc, Tb7980-HA and TbORC1/CDC6-Myc, Tb3120-HA
double expressers, which was not seen in the controls, indicating
interaction.
Figure 4. Identification of a T. brucei ORC1/CDC6-interacting protein as a putative orthologue of eukaryotic Orc4. A. Input (I) and
eluate (E) samples from immunoprecipitations (IPs) from procyclic form whole cell extracts are shown using antibody against HA (anti-HA) or against
Myc (anti-Myc). Anti-HA IP was performed from cells co-expressing TbORC1/CDC6-Myc (ORC-myc) and Tb13380-HA, or from control cells expressing
only Myc-tagged TbORC1/CDC6; anti-Myc IP was from cells co-expressing TbORC1/CDC6-Myc and Tb13380-HA, or from control cells expressing only
HA-tagged Tb13380. In all cases IP samples were separated on a 10% SDS-PAGE gel, transferred to a nylon membrane and probed with anti-HA
antibody (upper panel) or with anti-Myc antibody (lower panel). Size markers (kDa) are indicated. B A sequence comparison of the predicted Tb13380
polypeptide (translation of T. brucei gene ID Tb927.10.13380) with Orc4 proteins from a number of eukaryotes (black and grey boxing highlights
residues identical or conserved, respectively, in 50% of the sequences). For the following species Orc4 has been functionally or bioinformatically
identified: H. sapiens (Hsa, O43929), D. melanogaster (Dme, AAF47276.1), A. thaliana (Ath, CAE01428), S. cerevisiae (Sce, P54791), and T. thermophila
(Tth, 51.m00235). Also shown are putative Orc4 orthologues from further species: P. falciparum (Pfa, PF13_0189), Dictyostelium discoideum (Ddi,
DDB0168430), Cryptosporidium parvum (Cpa, cgd2_1550), Theileria annulata (Tan, TA12985), Giardia lamblia (Gla, ctg02_3) and Encephalitozoon
cuniculi (Ecu, NP_59761). The Tb13380 (ORC4) polypeptide is shown diagrammatically (number of amino acid residues is indicated), highlighting
regions of conservation around motifs involved in nucleotide binding and hydrolysis: Walker A and B boxes (A and B, red boxes), an Arginine finger
(R, orange box) and a Sensor 1 motif (S1, green boxes).
doi:10.1371/journal.pone.0032674.g004
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tion of TbORC4 (above), similar homology-based analyses give
few clues as to the potential functions of Tb7980 and Tb3120,
which may be kinetoplastid-specific. Tb7980 is predicted to be 441
amino acids in length and is conserved and syntenic across the
sequenced kinetoplastids (Tc00.1047053506247.280 in T. cruzi,
66% identity; LmjF36.6700 in L. major, 44% identity). The
strongest evidence that this protein may be ORC-like comes from
PHYRE searches, which suggest structural similarity with archaeal
Orc1/Cdc6 proteins: e.g. Cdc6p from Pyrobaculum aerophilum (80%
precision) and Orc1/Cdc6 from Sulfolobus Solfataricus (80%
precision). A putative Walker A motif (GPPGSGKT; residues
33–40) is present in the polypeptide sequence. Though further
motifs conserved in AAA
+ ATPases [9] could not be identified,
PFAM domain analysis suggested that the protein has similarity
with this enzyme family (data not shown). However, despite these
ORC-like features, we cannot meaningfully align the sequence of
Tb7980 with Orc1 and/or Cdc6 from eukaryotes or from
archaea, or with Orcs2–6. Tb3120 appears yet more diverged.
It is predicted to be 1018 amino acids in length, and has syntenic
orthologues in T. cruzi and L. major (Tc00.1047053511585.90 in T.
cruzi, 48% identity; LmjF01.0660 in L. major, 24% identity).
PHYRE searches provide only very weak evidence for putative
structural similarity with archaeal Orc1/Cdc6 proteins (data not
shown), and we cannot identify AAA
+ ATPase motifs that are
characteristic of ORC-related factors. As for Tb7980, homologous
proteins could not be identified in eukaryotes beyond the
kinetoplastids, or in archaea, by BLAST searches.
RNAi of all three ORC1/CDC6-interacting factors results in
growth defects in procyclic form T. brucei
To test whether TbORC4 (13380), Tb7980 and Tb3120 act in
nuclear DNA replication, an RNAi approach was used. For each
gene, and for TbORC1/CDC6, we generated constructs that
provide tetracycline-inducible expression of RNAi once trans-
formed into transgenic T. brucei PCF cells (Lister 427 pLew13
pLew 29) [49]. For each gene, RNAi induction had no detectable
effect on growth for up to 3 days (,7–8 population doublings; data
not shown), and thereafter (days 4–6) reduced but did not abolish
growth (Fig. S3). These relatively minor and slow to accumulate
effects on cell survival are consistent with a previous description of
growth kinetics in PCF T. brucei following TbORC1/CDC6 RNAi
(M. Klingbeil, pers.com.) [43]. Analysis of DNA content by fixing
and DAPI-staining the cells, and then counting the ratio of nuclear
(N) and kinetoplast (K) DNA visible in individual cells, revealed
potential replication-associated defects (Fig. 6; Fig. S4). As has
been described for TbORC1/CDC6 [43], and confirmed here,
RNAi of each gene resulted in the accumulation of aberrant cells
that do not conform to the 1N1K, 1N2K or 2N2K DNA
configurations that mark the normal course of cell division in T.
brucei [50]. In all cases, these aberrant cells were 0N1K ‘zoids’,
indicating that they had lost nuclear DNA, and their accumulation
was mirrored by similar reduction in 1N1K cell numbers,
suggesting they arise from cytokinesis of 1N2K cells that have
undergone kinetoplast replication and division but have failed to
complete nuclear DNA replication. The numbers of these zoids,
which never amounted to more than ,5% of the uninduced cells,
appeared to reflect the extent of mRNA loss following RNAi:
TbORC1/CDC6 and TbORC4 mRNA levels were relatively
strongly reduced (by ,85% and 75%, respectively) and zoids
made up 31% and 28%, respectively, of the population 6 days
after RNAi; Tb7980 and Tb3120 RNAi appeared less effective
(,40% and 30% mRNA reduction, respectively) and zoids
accumulated to a lesser extent (18% and 19% of the population
after 6 days). Despite this pronounced accumulation of zoids, we
have not to date been able to demonstrate directly a role for the
putative ORC-like factors in nuclear DNA replication. To do this,
we attempted to measure the extent of 59 bromodeoxyuridine
(BrdU) incorporation after RNAi by dot-blotting genomic DNA
and probing with anti-BrdU monoclonal antibody [51]. For each
of TbORC4, Tb7980 and Tb3120, we have been unable to detect
any reduction in BrdU signal four, six or even 10 days post-RNAi
induction (data not shown). However, it appears that this assay is
relatively insensitive unless RNAi is strongly penetrative. When we
analysed an RNAi clone that resulted in ,90% loss of TbORC1/
CDC6 mRNA, BrdU incorporation was detectably reduced after
four days, and this was concomitant with loss of 4C DNA and
increased amounts of S-phase and sub-2C DNA in FACS analysis
Figure 5. Co-immunoprecipitation demonstrates interaction between TbORC1/CDC6 and two novel factors. Input (I) and eluate (E)
samples from immunoprecipitations (IPs) using antibody against HA (anti-HA) are shown from procyclic T. brucei whole cell extracts of cells co-
expressing TbORC1/CDC6-Myc (ORC-myc) and either Tb7980-HA (IP labelled ORC1/CDC6-7980) or Tb3120-HA (IP labelled ORC1/CDC6-3120); a
control anti-HA IP is shown from cells expressing only Myc-tagged TbORC1/CDC6. Samples were separated by SDS-PAGE, transferred to a nylon
membrane and probed with anti-HA antibody (upper panel) or with anti-Myc antibody (lower panel). Bands corresponding with immunoglobulin
heavy chain (Ig), an anti-HA cross-reacting band (*) and with either HA-tagged Tb7980 or Tb3120 are indicated in the HA IP samples; size markers
(kDa) are indicated.
doi:10.1371/journal.pone.0032674.g005
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described by Godoy et al (2009) [43]. In contrast, in another clone
in which only ,75% loss of TbORC/CDC6 mRNA could be
seen, no effect on BrdU incorporation could be detected after 6
days and the perturbation of DNA content by FACS was
noticeably less severe (Fig. S5). As the maximum extent of mRNA
loss we have seen post-RNAi is ,75% for ORC4 (and is
substantially less for Tb7980 and Tb3120, despite screening a
number of transformant clones), it seems likely that the extent of
RNAi is below a threshold needed to see an effect on nuclear DNA
replication by the BrdU dot blot assay adopted. As a result, despite
the strikingly similar growth response of RNAi against each gene,
we cannot exclude that the formation of zoids in these conditions is
not a result of an effect on nuclear DNA replication but is due to
perturbation of the cell cycle.
ORC1/CDC6 and interacting factors are essential in
bloodstream form T. brucei
To date, ORC1/CDC6 function has been examined only in
tsetse fly-infective PCF T. brucei [43](M. Klingbeil, pers.com.). To
investigate the importance of ORC1/CDC6 and its interacting
factors in mammal-infective T. brucei, we perfomed RNAi in
bloodstream form (BSF) cells. For this the same RNAi constructs
used in PCF cells (above) were transformed into an established
transgenic T. brucei BSF cell line (Lister 427 pLew13 pLew90) [52]
that allows tetracycline-inducible, gene-specific RNAi. For each of
TbORC1/CDC6, TbORC4 and Tb7980 two independent transfor-
mant clones were selected and growth was followed in the absence
or presence of tetracycline (Fig. 7). Induction of RNAi resulted in
strikingly similar, severe growth defects for each gene. In the case
of ORC4 knock down, a reduction in growth was observed after
,8 hrs (essentially a single population doubling for such cells in
culture) relative to the uninduced controls. In all three knock-
downs, by 18–30 hrs post-induction of RNAi the cell concentra-
tions dropped, indicating cell death, and thereafter viable cells
became virtually impossible to count in these conditions. These
results suggest that each gene is essential for viability of BSF T.
brucei cells. For Tb3120 we have not yet identified a BSF
transformant clone in which RNAi could be demonstrated to
have occurred, so this gene was excluded from further analysis.
To determine whether the growth defects observed upon RNAi
induction correlate with a cell cycle defect, DNA content was
Figure 6. Effect of TbORC1/CDC6, TbORC4, Tb7980 and Tb3120 RNAi on procyclic form T. brucei.A .Analysis of nuclear (N) and
kinetoplast (K) DNA configurations in procyclic form T. brucei cells 4 and 6 days post-RNAi induction (induced by tetracycline; Tet+) against TbORC1/
CDC6, TbORC4 (13380), Tb7980 and Tb3120; for each gene, N and K configurations are also shown in cells without RNAi induction (Tet2). Graphs
depict the proportion of cells (derived by counting .200 DAPI-stained cells) with conventional 1N1K, 1N2K, or 2N2K configurations, or with any
aberrant configuration (others). In each graph, the insert shows the extent of loss of cognate mRNA by quantitative reverse transcriptase PCR (qRT-
PCR): levels of mRNA are shown four days after RNAi induction (Tet+) relative to the uninduced cells (Tet2), where qRT-PCR amplification has been
set as 1.0 (values are the mean of four experimental repetitions and vertical lines denote standard deviation). B Representative images, showing
aberrant cells with 0N1K DNA configuration seen 6 days after induction of RNAi of the gene indicated. Cells are shown with DNA stained by DAPI (N
and K are arrowed), and as merge of DAPI and phase contrast images.
doi:10.1371/journal.pone.0032674.g006
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The results for each gene were again strikingly similar. After RNAi
depletion of any of the three genes, an increase in cells with
.2N.2K DNA configuration was apparent (Fig. S6), rising from
,2% of the population at 8 hrs post-RNAi induction to
approximately 60% at 24–26 hrs post induction. In many cases
in these aberrant cells it was impossible to determine accurately N
and K numbers. Concomitant with this was a decrease in 1N1K
cells, reducing from ,70% to ,20% within the same time period.
This cell morphological defect was not observed in any control
(uninduced) population, where 1N1K cells constituted ,80% of
the population between 8 and 26 hrs, and aberrant cells never
amounted to more than ,3% of any population. To further
characterise the effect of depleting each protein on T. brucei DNA
content, FACS was used to examine PI-stained DNA from RNAi-
induced versus non-induced cells for up to 26 hrs (Fig. 8B). The
resulting FACS profiles showed that RNAi in each case resulted in
a decrease in the proportion of cells with 2C and 4C DNA content
(the former being depleted more rapidly), with a concomitant
increase in the proportion of cells with 8C DNA content. The
increase in the 8C cells appears consistent with the accumulation
of multinucleate cells observed in DAPI staining (Fig. 8A).
Discussion
In most eukaryotes examined to date, ORC has a conserved
architecture, composed of six subunits, Orcs1–6. Of these, Orcs1–
5 belong to the AAA+ ATPase family, which also contains the
Orc1-related factor Cdc6 [7,9,12,12], while Orc6 is less conserved
and appears not to be an AAA+ ATPase. Archaea, in contrast,
lack Orcs2–6 and instead possess one or more paralogues of a
protein, Orc1/Cdc6, that may fulfil both ORC and Cdc6
functions [2]. Previous work, based on bioinformatic analyses,
has suggested that T. brucei and related kinetoplastid parasites may
possess a simple archaeal-like system of a single origin designation
factor [42,43], and the single identified ORC-related protein has
been named ORC1/CDC6 to reflect this. Here, we have searched
for factors that interact with T. brucei ORC1/CDC6 in PCF (tsetse
fly infective) cells and identified three, each conserved in all
kinetoplastids. Of these, one is clearly a further ORC-like factor,
most closely related to eukaryotic Orc4 and very likely to be a T.
brucei orthologue whose sequence is sufficiently diverged to have
escaped detection by similarity searches. The two other proteins,
though displaying sequence features that suggest they may be
ORC-related, are so diverged that we cannot assign orthology. A
further TbORC1/CDC6-interacting factor, TbORC1b, has been
described [45], which was not recovered in the IP approach we
adopted and also has no clear ORC subunit orthology. The
identification of TbORC4 indicates that ORC in T. brucei is closer
to the eukaryotic paradigm than previously thought (Fig. 9).
However, as we cannot identify orthologues of Orcs 2, 3, 5 or 6,
ORC may yet be highly diverged.
Three evolutionary scenarios might explain T. brucei ORC
divergence. First, Orc2, Orc3, Orc5 and Orc6 are truly absent
and this is because ORC structure in T. brucei reflects a simplified,
ancestral state of this machinery [21,43]. Alternatively, TbORC1/
CDC6 and TbORC4 may be the only survivors of streamlining of
the six-component ORC machinery, perhaps reflecting the
generalised demands of a parasitic lifestyle [36]. Finally, it is
possible that all ORC subunits are present in T. brucei but most
have become highly diverged due to lineage-specific demands on
DNA replication (for instance, constraints on ORC recruitment in
a genome in which gene expression is nearly exclusively
polycistronic and mRNA abundance controlled post-transcrip-
tionally) [53]. Searching the sequenced genomes of a wide range of
protistan organisms provides some insight into this (Table 1; Text
S1). The absence of clear homologues of each of the six ORC
subunits is not uncommon, and the presence of a single protein
related to both Orc1 and Cdc6 is not limited to kinetoplastids [54].
Within the Opisthokont supergoup, six ORC proteins and Cdc6
as a separate protein are found in yeasts and metazoans, and the
same factor complement is seen in the social amoeba Dictyostelium
discoidium. However, in another Opisthokont, Encephalitozoon
cuniculi, and in Entamoeba histolytica, an Amoebazoan related to D.
discoidium, fewer factors could be identified. E. cuniculi is an
intracellular microsporidian parasite, related to fungi such as yeast,
and considerable evidence suggests E. cuniculi is undergoing a
process of genome reduction [55,56]. Here, then, the absence of
ORC components may be genuine and reflect relatively recent
evolutionary loss, illustrating that eukaryotic ORC function can be
adapted to a streamlined version lacking some components. In the
Excavata supergroup, which includes kinetoplastids, Orc1 and
Cdc6 were nearly always identified bioinformatically as a single
protein (only in Trichomonas vaginalis were both Orc1 and Cdc6
found) [57], and in no sequenced genome could all six ORC
components be found. However, the repertoire of genes that were
found was not consistent in each organism and, perhaps tellingly,
the genome of Naegleria gruberi possessed the highest number of
identifiable ORC-related factors [36]. Though it is unclear
whether the Excavata is a legitimate evolutionary grouping, N.
Figure 7. RNAi of TbORC1/CDC6, TbORC4 and Tb7980 in bloodstream form T. brucei cells results in rapid growth arrest. Growth
curves are shown for bloodstream form T. brucei cells in the absence or presence of tetracycline (tet2, shown as solid line, and tet+, dashed line,
respectively), which induces RNAi, targeting either TbORC1/CDC6, TbORC4 (Tb13380),o rTb7980 mRNA. For each factor, cell density over time was
examined in two clonal RNAi cell lines (identified by C).
doi:10.1371/journal.pone.0032674.g007
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genome has been sequenced. Fig. 9 compares putative conserved
ORC factors in N. gruberi and T. brucei. The N. gruberi factors, like
those of T. brucei, are highly diverged (data not shown), but appear
most related to Orc1, Orc4, Orc2 and Orc6, based on BLAST
searches and sequence alignments [36](data not shown). This
argues that ORC architecture in T. brucei and kinetoplastids, like
that in E. cuniculi, is not ancestral but reflects either evolutionary
divergence or loss of the constituent proteins. The latter scenario
would be consistent with a much broader evolutionary selection
for genome compaction in these parasites [36].
Irrespective of the arguments for and against the presence or
absence of ORC subunits in extant eukaryotes, including T. brucei,
it is clear that the most commonly conserved proteins are Orc1
and/or Cdc6 and Orc4 (Table 1). Only in two of the organisms
that we have analysed can Orc4 not be identified; in most cases it
is readily identified by sequence homology, and we show here that
it is present in T. brucei, T. cruzi and L. major. Orc1 and Cdc6 are
found in all organisms, albeit in some cases as one indistinguish-
able protein (see below). These data suggest that these are the core
factors of the ORC machinery: the most resistant to loss during
genome streamlining, or to change is sequence due to evolutionary
pressures on ORC function. This suggests that these are central to
the functioning of ORC, which has experimental support. The
structure of eukaryotic ORC has not been determined to high
resolution, but electron microscopy has allowed the architecture of
ORC and the Orc1–5 subcomplex to be determined at low
resolution in S. cerevisiae and D. melanogaster [18,22]. The inferred
architecture (Fig. 9) suggests that Orc4 and Orc1 are adjacent in
the structure, with Orc4 positioned centrally and contacting Orc5
and Orc2 [58]. Functional interaction is also seen in stimulation of
Orc1’s ATPase by the arginine finger of Orc4, a co-operative
activity needed for pre-RC function [59]. Association of Orc1 and
Orc4 is also seen at S. cerevisaie ARS origins, where they bind near
A elements, distinct from Orc2 binding around B1 elements [60].
In S. pombe, Orc4 appears to have assumed a yet more central role,
since it has an N-terminal extension containing nine AT-hook
DNA binding motifs that are needed for assembly of ORC at
origins [23,61–63]. That Orc4 is key to ORC association with
DNA is seen by the finding that it is the ORC subunit that remains
Figure 8. Effect of TbORC1/CDC6, TbORC4 and Tb7980 RNAi on bloodstream form T. brucei.A .Analysis of nuclear (N) and kinetoplast (K)
DNA configurations in bloodstream form T. brucei cells at time points following RNAi induction (induced by tetracycline; Tet+) against TbORC1/CDC6,
TbORC4 (13380) and Tb7980; for comparison, N and K configurations are shown in cells without RNAi induction (Tet2). Graphs depict the proportion
of cells (derived by counting .200 DAPI-stained cells) with conventional 1N1K, 1N2K, or 2N2K configurations, or with any aberrant configuration
(grouped as others). B. FACS profiles of propidium iodide (PI)-stained cells after RNAi induction (Tet+) are shown as histograms after FACS sorting,
sampled at the time points post-induction (control cells, without RNAi induction (Tet2), are shown sampled at the time shown, corresponding to
growth from an equivalent starting density to the RNAi- induced cells). Peaks corresponding with cells containing 2C and 4C DNA content are
indicated, as is the peak position for cells with 8C content (C represents haploid DNA content).
doi:10.1371/journal.pone.0032674.g008
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extracts [64]. Finally, during assembly and disassembly of human
ORC on DNA, Orc4 has been shown to be a central mediator
[17,65]: ATP binding to Orc4 is needed to allow interaction of the
subunit with an Orc2/3/5 sub-complex, which then recruits Orc1
and binds DNA; disassembly of ORC may be mediated by Orc4
ATP hydrolysis after ubiquitin-mediated proteolysis of Orc1.
Given the above, is it possible that ORC in T. brucei consists only
of TbORC4 and TbORC1/CDC6, or are other ORC subunits
present but so diverged that they have escaped detection? The
predicted T. brucei ORC4 polypeptide may not to be a functional
ATPase, as it has degenerate Walker A and B boxes (Fig. 4). In
most eukaryotes Orc4 and Orc5 are highly conserved ATPases,
while Orc2 and Orc3 are less conserved but are proposed to have
AAA+ ATPase structure [7,12]. It is thought that ATP binding
and hydrolysis by the ORC subunits are needed for conforma-
tional changes associated with ORC assembly, DNA binding,
interaction with MCM in the pre-RC, and disassembly [12,15–
18]. In this regard it may be significant that AAA+ proteins
function as multimeric assemblies, with the ATPase active sites
formed at the interface of protomers. Thus, each protein has a cis
face (containing Walker A and B residues) and a trans face that
juxtaposes to the cis face of an adjacent protomer. Interestingly,
the trans residues of the T. brucei ORC4 appear to be conserved,
indicating that they could form a functional active site with an
adjacent protomer (most likely TbORC1/CDC6) [58]. In
contrast, the cis face of T. brucei ORC4 lacks a number of
conserved and functionally important residues, suggesting that it
cannot contribute to a functional active site. Perhaps this reflects
the absence of further ORC subunits in T. brucei such that
TbORC4 acts as a ‘‘book-end’’ in the overall ORC assembly. If
correct, the ATPase activity in T. brucei ORC is concentrated in
TbORC1/CDC6 (this protein shows conservation of all motifs),
suggesting conformational changes here act in TbMCM recruit-
ment.
The above suggestions are consistent with findings in humans,
where Walker A (ATP binding) mutations in Orc4 (and Orc5)
impair ORC assembly in vitro [17]. However, ATPase functionality
for Orc4 may not be universal, since S. cerevisiae Orc4 also has a
degenerate Walker A motif (Fig. 4); here Orc1 and Orc5 may be
the focus for ATP binding [12,66]. Moreover, D. melanogaster ORC
forms and binds DNA when Orc4 or Orc5 are mutated in the
Walker A box [67]. It may then be that T. brucei does indeed
possess a multiprotein ORC, of which Tb7980, Tb3120 and
TbORC1b may constitute further subunits. Nevertheless, the
considerable sequence divergence of these factors might indicate
that the detailed architecture and functioning of ORC can be
tailored to the specific needs of individual organisms. While there
is no clear orthology between any T. brucei nuclear replication
factor thus far identified and Orc2, Orc3, Orc5 or Orc6, the
analysis we present here on the phyletic distribution of protistan
ORC factors suggests that these ORC components are less
constrained in evolution than Orc1 and/or Cdc6 and Orc4.
Indeed, Orc3 and Orc2 have already been considered to show
greater divergence than Orc1, Orc4 and Orc5 within the more
limited range of eukaryotes considered until now [7]. The lack of
clear orthology of Tb7980, Tb3120 and TbORC1b might then
simply reflect the considerable evolutionary distance of T. brucei
from most well-studied eukaryotes. However, we do not exclude
the interesting possibility that these factors provide replication-
related functions specific to this eukaryotic lineage.
The severity and nature of the phenotypes observed following
RNAi of TbORC4, Tb7980 and Tb3120 closely mirror those of
TbORC1/CDC6 in PCF and BSF T. brucei, suggesting functional
overlap. Whether this is also true of TbORC1b, for which RNAi
has not been reported, we cannot say. As we have stressed,
formally we have not demonstrated that each gene product acts in
nuclear DNA replication, though we suspect it is likely that they
do, given the striking phenocopying we report. Nonetheless, the
nature and timing of the RNAi phenotypes are distinct between
the two life cycle stages. In PCF cells, little growth impairment is
seen until around 72–96 hrs (,6–10 population doublings) post-
RNAi induction, at which time anucleate cells slowly accumulate
[43](M.Klingbeil, pers.com.). The greater impact that RNAi of
TbORC1/CDC6 or its interacting factors has in BSF T. brucei is
especially striking because at most we could detect (by quantitative
RT-PCR) loss of around 40% of TbORC1/CDC6 mRNA post
RNAi (12 hours), compared with up to 90% loss in PCF cells.
These observations are consistent with suggestions, from both
RNAi and drug treatment studies, that a checkpoint monitoring
progression from mitosis to cytokinesis is absent in PCF T. brucei
but present in BSF cells [68,69]. Though no work to date has
examined the link between nuclear DNA replication and cell cycle
checkpoints in T. brucei, perturbation of ORC function activates
DNA damage and spindle checkpoints in yeast [70,71]. Despite
this, we cannot yet exclude the possibility that the RNAi
phenotypes we see reflect non-replication functions [72] for
TbORC1/CDC6 and for the ORC1/CDC6-interacting factors,
and perhaps the greater severity of RNAi in BSF cells is because
these non-replication roles assume greater prominence in mammal
life cycle stages.
An intriguing feature of ORC in T. brucei, as well as in G. lamblia
[54] and N. gruberi [36], is the putative absence of distinct Orc1
and Cdc6 factors. Orc1 and Cdc6 are very similar in sequence [7]
and so it is highly unlikely that database searches would have
Figure 9. Origin Recognition Complex architecture in the
eukaryotes S. cerevisiae, T. brucei and N. gruberi. The architecture
of the Origin Recognition Complex (ORC; composed of Orc subunits
numbered 1–6), bound to the Orc1-related factor Cdc6 and to DNA
(black line), is shown for S. cerevisiae based on work by Chen et al [22];
the specific arrangement of Orcs 2–5 is inferred from Moreno del-Alamo
[58]. In T. brucei, recognisable ORC subunit orthologues are identified,
while subunits that are absent or highly diverged are shown as dotted
circles containing question marks. The T. brucei ORC subunit indicated
as Orc1 appears to be a bi-functional Orc1-Cdc6 protein, and it is
unknown if it therefore occupies a distinct architectural position in the
ORC or adopts a distinct structure. Putative ORC subunits identified
bioinformatically in N. gruberi, a free-living relative of T. brucei, are
shown for comparison; here again, Orc1 appears to be an Orc1-Cdc6
fusion.
doi:10.1371/journal.pone.0032674.g009
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significantly in sequence. As it has been argued, the fusion of Orc1
and Cdc6 functions in a single protein may be representative of an
ancestral molecule, as is found in archaea [43]. However, it must
now be considered that T. brucei ORC1/CDC6 does not function
in isolation, but as part of an ORC containing at least one other
factor. The functional consequences of this unusual arrangement
are unclear. In other eukaryotes, Cdc6 becomes associated with
ORC in a cell cycle-specific manner, inducing ATP-dependent
conformational changes that cause recruitment of the MCM
helicase, via Cdt1 [12,16,24,28,73]. Expression of T. brucei and T.
cruzi ORC1/CDC6 is not cell cycle-dependent; instead the protein
associates with chromatin in all cell cycle stages [43]. This appears
to rule out the possibility that TbORC1/CDC6 is functionally
related to Cdc6 and not Orc1 [21]. However, if Cdc6 is
constitutively fused to ORC, this raises questions regarding how
and when the MCM replicative helicase is recruited, with
implications for the regulation of origin firing in these parasites.
This is a problem shared with archaea, and we considered the
possibility that T. brucei ORC might interact directly with MCM.
While our interaction data are compatible with T. brucei MCM(2–
7) possessing a conventional eukaryotic heterohexameric MCM
structure with a conserved subunit interaction network, we were
unable to detect interactions between TbORC1/CDC6 and
TbMCM, using a number of approaches. More specifically, IP
of HA-tagged TbMCM3, TbMCM6 or TbMCM7 did not reveal
coIP of myc-tagged TbORC1/CDC6 from whole cells extracts.
Conversely, IP of myc-tagged TbORC1/CDC6 did not coIP HA-
tagged TbMCM2 or TbMCM7. Finally, IP and mass-spectrom-
etry analyses of HA-tagged MCM subunits or Myc-tagged
TbORC1/CDC6 did not reveal evidence for interaction. These
data do not agree with experiments from Dang and Li [45], who
observed interaction between epitope tagged TBMCM3 and both
TbORC1/CDC6 and TbORC1b. Why these analyses should
reach different conclusions, especially when both tested
TbMCM3-TbORC1/CDC6 interaction, is unclear. It is possible
that any ORC-MCM interaction is limited to the nucleus or to
specific cell-cycle stages, and this may be obscured by analysing
whole cell extracts, as we did. Alternatively, any such interaction
may be relatively weak or transient and not maintained by the IP
conditions we employed. However, unlike in archaea, where direct
Orc1/Cdc6 interaction has been observed in a number of species,
interaction between ORC and MCM in eukaryotes has not
previously been described, except where Cdt1 was artificially
tethered to Orc1–5 [28]. It therefore remains possible that a Cdt1-
like mediator is present in T. brucei to recruit the conventionally
eukaryotic MCM helicase. Such a mediator remains to be
identified, and it is unclear what component, if any, of the ORC
that we describe here it might act upon. Indeed, the limited
homology between the putative T. brucei ORC components
described and the canonical six-component eukaryotic ORC
suggests that further characterisation is needed of ORC in this
parasite and in protists.
Materials and Methods
Trypanosoma brucei strains, growth and transformation
T. brucei BSF cells were all of strain Lister 427 and were used
and grown at 37uC in HMI-9 medium [74]. PCF cells were of
strain Lister 427 or TREU927 and were grown in SDM-79
Table 1. A comparison of the presence (+), absence (2) or number of detectable ORC subunit and Cdc6 proteins encoded by the
genomes of a range of eukaryotic species, which are grouped into taxa and into five supergroups; ‘+’ in parenthesis indicates that a
single protein is found that is related to both Orc1 and Cdc6.
Supergroup Taxon Organism Orc1 Orc2 Orc3 Orc4 Orc5 Orc6 Cdc6
Excavata
a Diplomonadida G. lamblia (+) 22+ 22(+)
Euglenozoa T. brucei (+) 22+ 22(+)
T. cruzi (+) 22+ 22(+)
L. major (+) 22+ 22(+)
Heterolobosea N. gruberi (+) + 2 + 2 + (+)
Parabasala T.vaginalis ++2 + 22+
Chromalveolata Stramenopile T. pseudonana ++2222+(2)
Apicomplexa T. annulata ++2 + 22+
P. falciparum ++2 ++2 +
C. parvum ++2 ++2 +
Ciliophora T. thermophila ++2 ++2 +
Plantae Viridiplantae A. thaliana +++++++
Amoebozoa Entamoebidae E. histolytica + 22222+
Mycetozoa D. discoideum +++++++
Opisthokonta Microsporidia E. cuniculi ++2 + 22+
Fungi S. pombe +++++++
S. cerevisiae +++++++
Metazoa D. melanogaster +++++++
H. sapiens +++++++
athe supergroup Excavata is often split into two supergroups, one containing Euglenozoan, Heterolobosean and Jackobid (not shown) organisms, and the other
containing Parabasalid, Diplomonad and Oxymonad (not shown) organisms.
doi:10.1371/journal.pone.0032674.t001
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haemocytometer (Weber Scientific).For transformation,PCF cells at
a density of 5–10610
6 cells.ml
21 were centrifuged at 6006 g. for
10 min at RT and the supernatant removed and preserved for use as
‘‘conditioned medium’’. ,2.5610
7 cells were resuspended in 0.5 ml
of ice-cold Zimmerman medium (132 mM NaCl, 8 mM KCl,
8m M N a 2HPO4, 1.5 mM KH2PO4, 0.5 mM MgAc2,a n d
0.06 mM CaAc2, pH 7.5) and 10 mgo fl i n e a r i s e dD N A ,i na
maximum volume of 10 ul of sterile double-distilled water, was
added to the cells, which were subjected to two rounds of
electroporation with a Bio-Rad Gene Pulser II (1.5 kV and 25 mF
capacitance). The cells were then transferred into 10 ml of pre-
warmed SDM79 medium and incubated at 27uC overnight. To
selectforantibiotic-resistanttransformants,conditionedmediumwas
prepared by adding 10% (v/v) FCS, 15% (v/v) sterile filtered
medium (see above), and 75% (v/v) SDM79 medium supplemented
with appropriate antibiotics. 100 ul and 1 ml of the population of
electroporated and recovered parasites was added separately to
20 ml of conditioned medium and distributed across a 96 well plate
(175 ml in each well). Outgrowth of antibiotic-resistant transformant
clones was monitored until 10–14 days later. Transformation of BSF
cells used an AMAXANucleofactor kit, optimised for human T-cells
according to the manufacturer’s protocol (Cat# VPA-1002, Amaxa
Biosystems). ,2.5610
7 cells, from a culture at 1–2610
6 cells.ml
21,
were resuspended in 0.5 ml ice-cold Zimmerman medium supple-
mented with glucose (1% w/v) and transformed with 10 mgo fD N A .
After nucleofection, the cells were serially diluted 1:10, 1:100 and
1:1000 in 30 ml HMI-9 without antibiotic, distributed in 24 well
plates (1.0 ml per well) and incubated 6–12 hrs for recovery. After
recovery,1 mlofHMI-9mediumcontainingantibioticwasaddedto
each well and outgrowth of transformants monitored for up to 7–10
days. DNA to be transformed was linearised using appropriate
restriction enzymes in a final reaction volume of 300 ml containing
,100 mg of DNA; the reaction mixture was incubated overnight,
ethanol precipitated, resuspended in sterile double-distilled H20a n d
the DNA concentration measured using a Nanodrop spectropho-
tometer (ThermoScientific).
Epitope tagging
All proteins in this study were C-terminally epitope tagged, using
constructs derived from the plasmid pNAT
12MYC [76]. To Myc tag
TbORC1/CDC6, a C-terminal coding fragment of the ORF,
excluding the stop codon, was PCR-amplified with the primers
CTOL43 and CTOL44 (all primer sequences are available on
request) and cloned into the above vector. The resulting construct
was digested with XhoI and transformed in TREU927 PCF cells,
which were selected with 10 mg.ml
21 blasticidin. TbMCM subunits
wereC-terminallyHAtaggedbymodifyingthepNAT
12MYCvector:
the blasticidin resistance gene was replaced by phleomycin resistance, and
the 12Myc-encoding sequence replaced with a sequence encoding 6
repeats of the HA epitope; C-terminal fragments of each TbMCM
subunit gene were then PCR-amplified (primers: CTOL55 and
CTOL56, MCM2; CTOL61 and CTOL62, MCM3; CTOL59 and
CTOL60, MCM4; CTOL57 and CTOL58, MCM5; CTOL51 and
CTOL52, MCM6; and CTOL53 and CTOL54, MCM7)a n d
clonedintothe resultingHA-tagging vector,replacingtheTbORC1/
CDC6 fragment. The resulting constructs were digested with ClaI,
HpaI, XhoI, PvuII, PvuII and AgeI, respectively, prior to transforma-
tion in TREU927 PCF T. brucei, and transformants selected with
10 mg.ml
21 zeocin.
RNAi analysis
T. brucei PCF strain 427 pLew29-pLew13, and BSF form strain
pLew90-pLEW13, developed by Wirtz et al [52]were used,
constitutively co-expressing T7 RNA polymerase and Tet
repressor. Gene fragments were amplified by PCR and cloned
in to the vector pZJM [77], where they are flanked by opposing T7
promoters and Tet operator sequences. RNAi fragments were
generated with the primers CTOL01 and CTOL02 (TbORC1/
CDC6), CTOL63 and CTOL64 (TbORC4, 13380) or CTOL67
and CTOL68 (Tb7980). Prior to transformation, the constructs
were digested with NotI, allowing integration into the rDNA
arrays. Transformant clones were selected with 10 mg.ml
21
zeocin (PCF) and 2.5 mg.ml-1 phleomycin (BSF). To quantify
levels of mRNA, primers CTOL7 and CTOL8 (TbORC1/
CDC6), ORC4qPCRF4 and ORC4qPCRR4 (TbORC4, 13380),
ORC2qPCRF and ORC2qPCRR (Tb7980) and 3120qPCRF and
3120qPCRR (Tb3120) were used; GPI8 primers (CTOL27 and
CTOL28) were used as a control. SYBRH Green PCR Master Mix
(Applied Biosystems) was used for PCR in 96 well plates. A master
mix for 30 reactions was made in which each reaction had 12.5 ml
of SYBR mix, 1.0 ml of each primer (300 nM stock), 9.5 mlo f
dH2O, and 1.0 ml cDNA. Reactions were run on an ABI Prism
7000 thermocycler and mRNA levels quantified from amplifica-
tion according to the manufacturer’s instructions; conditions for all
reactions were 50uC for 2 min, 95uC for 10 min, followed by 40
cycles of 95uC for 15 sec and 60uC for 1 min. For DAPI staining
of T. brucei DNA, 5610
5 cells were centrifuged at 6006g, washed
twice in PBS and resuspended in 100 ml of PBS. 50 ml was spread
on a glass microscope slide, air-dried, and fixed in methanol at
220uC. The slides were then removed from the methanol, which
was allowed to evaporate at RT, rehydrated in PBS, and
Vectashield with DAPI (VectorLabs) was added. Slides were
sealed with nail varnish and examined under UV light on a Zeiss
Axioplan microscope. Images were captured using a Hamamatsu
ORCA-ER digital camera, and Openlab version 3.0.3 software
was used for processing images. For FACS analysis, 10
6 cells were
pelleted by centrifugation at 6006 g, washed once in PBS, and
resuspended in 70% methanol, 30% PBS. The cells were then
incubated at 4uC overnight for fixation, washed in 10 ml ice-cold
PBS, resuspended in 1 ml of PBS containing 10 mg.ml
21
propidium iodide (SIGMA) and 10 mg.ml
21 RNase A (SIGMA),
and incubated at 37uC for 45 min. FACS was performed with a
Becton Dickinson FACSCalibur using detector FL2-A and an
AmpGain value of 1.75. To measure BrdU incorporation, 10
8
PCF T. brucei cells were labelled with 50 mM BrdU and 50 mM2 9-
deoxycytidine in SDM-79 and incubated at 27uC for 60 mins.
After incubation, the cells were harvested by centrifugation at
6006 g for 10 minutes, and total DNA was extracted using a
Qiagen DNeasy Kit according to manufacturer’s instructions.
DNA samples were then incubated for 1 hr at 37uC with
33 mg.ml
21 RNase A (Sigma R4642). The amount of purified
DNA was determined using a NanoDrop (Thermo Scientific) and
2 mg of total DNA was incubated with 10 volumes of 0.4 N NaOH
solution for 30 min at room temperature (RT) and kept on ice.
The DNA solution was then neutralised with an equal volume of
1 M Tris?HCl (pH 6.8) and dot-blotted (50 ng in 5 ml) onto a
nitrocellulose membrane (Amersham) and allowed to air dry. The
DNA was fixed twice on the membrane using an ultraviolet cross-
linker Stratalinker (Stratagene) and incubated with mouse anti-
BrdU monoclonal antibody (1:2,000 dilution, B2531, Sigma) in
buffer containing TBST (20 mM Tris?HCl, pH 7.6, 136 mM
NaCl, and 0.05% Tween 20) and 1% non-fat milk for 1 hr at RT.
The membrane was then washed with TBST three times for
10 mins each at RT, and incubated with horseradish peroxidase-
conjugated anti-mouse IgG antibody (1:5,000 dilution) for 1 h at
RT. Next the membrane was washed three times again with TBS-
T for 20 min at RT and BrdU signal detected either using an
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tyOne software (BioRad), or exposure to X-Ray film.
Immunoprecipitation
50 ml of M-280 IgG-coated magnetic Dynalbeads (Invitrogen)
was pre-blocked by washing, twice, with 1 ml of block solution
(0.05% BSA in PBS), each time collecting the beads using a
magnetic rack and discarding the supernatant, before finally being
resuspended in 250 ml block solution. 5 mg of antibody specific to
the desired epitope tag was then added to the beads/block solution
and incubated, rotating, at 4uC overnight. The beads were then
washed 3 times in 1 ml block solution and resuspended in 100 ml
block solution. Whole cell T. brucei extract was prepared by
centrifugation of 10
8 cells at 20006 g for 10 minutes. After
washing twice in ice-cold PBS, the cells were resuspended in 2 ml
WCE buffer (50 mM HEPES pH 7.55, 100 mM NaCl, 1.0 mM
EDTA, 1.0 mM EGTA, 10% glycerol, 1% Triton X100 and
protease inhibitors) and lysed on ice for 1–2 hours. The cell lysate
was then centrifuged at 150006ga t4 uC for 30 mins and a sample
of supernatant aliquoted and stored at 220uC to serve as ‘input’.
The rest of the supernatant was added to the beads (prepared
above) and incubated for 2 hrs. After incubation, the samples were
washed seven times with 1.0 ml ice-cold wash buffer (50 mM
HEPES pH 7.55, 500 mM LiCl, 1.0 mM EDTA, 1.0 mM
EGTA, 0.7% Na deoxycholate, 1% NP40 and protease inhibitors),
and then finally washed with 1 ml TE wash buffer (10 mM
Tris.HCl pH 8.0, 50 mM NaCl and 1 mM EDTA). After the TE
wash step, the samples were centrifuged at 10006g for 3 mins at
4uC, residual TE wash buffer carefully removed, and incubated in
220 ml of Elution buffer (50 mM Tris.HCl pH 8.0, 10 mM
EDTA, 1% SDS) at 65uC for 30 mins, with intermittent vortexing
every 2–5 mins. The beads were then centrifuged for 1 min at
16,1006g at room temp. and 200 ml of the supernatant removed,
which served as the ‘eluate’. For coIP analysis, 20 ml of input and
eluate samples were separated by SDS-PAGE and analysed by
western blotting (using anti-Myc and anti-HA monoclonal
antibodies; Millipore). For protein identification, the eluate
samples were also separated by SDS-PAGE and visualized by
staining with colloidal coommassie; protein bands were excised
and analysed by Liquid Chromatography-Electrospray Tandem
Mass Spectrometry at the University of Glasgow Sir Henry
Wellcome Functional Genomics facility, or at the University of
Dundee proteomics facility.
Yeast two-hybrid
Yeast two-hybrid interaction assays were carried out using the
Matchmaker Gold yeast two-hybrid system (Clontech). The MCM
ORFs were PCR-amplified (primers available on request) and
cloned into pGADT7 and pGBKT7 vectors, which were then
transformed into yeast strains Y2H Gold and Y187, respectively.
Transformants were selected on SD/-Trp/-Leu media. To test
interactions between MCM proteins, at least two clones of cell
lines containing both vectors were plated onto SD/-Trp/-Leu/-
His with and without 125 ng/ul Aureobasidin A or 2.5 mM 39
aminotriazole. Interactions were classified as being ‘strong’ if
growth occurred on both media, ‘weak’ if growth occurred only on
media without Aureobasidin A or 39 aminotriazole.
Supporting Information
Figure S1 Yeast 2-hybrid analysis of interactions be-
tween T. brucei MCM subunits. A. Growth of yeast clones
co-expressing individual MCM subunits (numbered 2–7, indicat-
ing MCM2–7) as fusions with the Gal DNA binding domain
(pGBK-MCM) and with the Gal activation domain (pGAD-
MCM) is shown (2 clones for each pair); as a contro,l the MCM-
DNA binding fusions are shown co-expressed with the Gal
activator domain unfused to any protein (pGAD-Empty). Growth
on minimal medium lacking tryptophan, leucine and histidine (-
T-L-H), or supplemented with Aureobasidin A (-T-L-H+AbA),
indicates weak and strong interactions, respectively; growth on
medium lacking only tryptophan and lecuine (-T-L) shows that
the cells that cannot grow through interaction are viable. B. The
MCM3-Gal DNA binding domain fusion (pGBK-MCM3 co-
expressed with pGAD-Empty) appeared to show some autoacti-
vation, so this interaction analysis was repeated, and further
tested by growth on mimimal medium lacking tryptophan,
leucine and histidine and supplemented with 2.5 mM 39
aminotriazole (-T-L-H+3-AT). C. The MCM6-Gal activator
domain fusion (pGBK-MCM6) appeared to show extensive weak
interactions, and this was retested by analysing growth of four
independently generated yeast clones (numbered 1–4) co-
expressing the protein with MCM-Gal DNA binding domain
fusions.
(PDF)
Figure S2 A phylogenetic tree of eukaryotic ORC
proteins and the novel, putative T. brucei ORC proteins.
A neighbour-joining phylogenetic tree is shown that was
generated from a ClustalX alignment of validated or putative
ORC subunit polypeptides; the lengths of the arms in the tree are
proportional to the size marker, where the line length indicates 10
amino acid changes per 100 amino acids. Hsa, Homo sapiens;
Dme, Drosophila melanogaster; Ath, Arabidopsis thaliana; Sce,
Saccharomyces cerevisiae; Ecu, Encephalitozoon cuniculi;D d i ,Dictyoste-
lium discoideum;P f a ,Plasmodium falciparum; Cpa, Cryptosporidium
parvum;T a n ,Theileria annulata;T t h ,Tetrahymena thermophila; Gla,
Giardia lamblia;T v a ,Trichomonas vaginalis;E h i ,Entamoeba histolytica;
Tps, Thalassiosira pseudonona;T b r ,Trypanosoma brucei;L m a ,L.
major;T c r ,T. cruzi. Genbank accession numbers are provided in
Text S1.
(PDF)
Figure S3 RNAi of TbORC1/CDC6, TbORC4, Tb7980
and Tb3120 in procyclic form T. brucei cells. Growth
curves are shown for procyclic form T. brucei cells in the absence or
presence of tetracycline (tet2, shown as solid line, and tet+, dashed
line, respectively), which induces RNAi, targeting either TbORC1/
CDC6, TbORC4 (Tb13380), Tb7980 or Tb3120 mRNA. For each
factor, cell density over time was examined and cell counts are
shown from 3 days post-RNAi induction.
(PDF)
Figure S4 Representative images of procyclic form T. brucei cells
after RNAi induction against TbORC1/CDC6, TbORC4 (13380),
Tb7980 or Tb3120 are shown 6 days post RNAi-induction; all
images are shown as an overlay of DAPI-stained and phase
images, and arrows highlight ‘zoid’ cells that lack nuclear DNA
but retain kDNA.
(PDF)
Figure S5 Comparison of RNAi phenotypes at two
different levels of ORC1/CDC6 mRNA knockdown in
procyclic form T. brucei. Quantitative reverse-transcriptase
PCR (qRT-PCR) to determine TbORC1/CDC6 mRNA levels
after RNAi is shown (left) for cells in which RNAi leads to ,90%
loss of mRNA (top) and 75% loss (bottom), 96 hours post-RNAi
induction. The abundance of TbORC1/CDC6 cDNA from
RNAi-induced cells (Tet+, black bar) is shown to relative to control
cells without TbORC1/CDC6 RNAi (tet2, grey bar). The
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normalised to 1.0; values are the means from at least three
experimental repetitions and vertical lines denote standard
deviation. In the middle, histograms are shown of propidium
iodide-stained (PI) DNA from cells after FACS sorting, sampled
pre- and post - induction of RNAi against TbORC1/CDC6
(2Tet and+Tet, respectively); the histograms refer to the 90% and
75% RNAi cells to the left. Peaks corresponding with cells
containing 2C and 4C DNA content are indicated, as is the peak
position for cells with 8C content (C represents haploid DNA
content). The rightmost diagram shows dot-blots of T. brucei DNA
probed with anti-BrdU antibody. DNA is shown from the cells
incubated with BrdU after RNAi was induced by tetracycline
(+Tet) for 96 or 144 hrs, targeted against either TbORC1/CDC6
or Tb927.6.5070 (as a control); in all cases RNAi-induced cells are
compared with control cells in which RNAi was not induced
(2Tet). As before, the TbORC1/CDC6 dot blots refer to the 90%
and 75% RNAi cells shown the far left; RNAi against
Tb927.6.5070 was quantified by qRT-PCR and shown to reduce
mRNA levels by ,90% (data not shown).
(PDF)
Figure S6 Representative images of aberrant bloodstream form
T. brucei cells after RNAi induction against TbORC1/CDC6,
TbORC4 (13380) or Tb7980 are shown at the time points
indicated; DAPI stain (DAPI), phase contrast (PHASE), and an
overlay of the DAPI and phase images (MERGE) are indicated.
(PDF)
Text S1 Accession or genome identification numbers
for the putative Origin Recognition Complex subunits
used in this study.
(PDF)
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